Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung. Effect of Mulligan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results